BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10474063)

  • 1. Neurochemical substrates and neuroanatomical generators of the event-related P300.
    Frodl-Bauch T; Bottlender R; Hegerl U
    Neuropsychobiology; 1999; 40(2):86-94. PubMed ID: 10474063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry of mood and emotion.
    McGeer PL; McGeer EG
    Annu Rev Psychol; 1980; 31():273-307. PubMed ID: 6102450
    [No Abstract]   [Full Text] [Related]  

  • 3. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis.
    Chesselet MF
    Neuroscience; 1984 Jun; 12(2):347-75. PubMed ID: 6146946
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemical changes following the administration of precursors of biogenic amines.
    Smith JE; Lane JD; Shea PA; McBride WJ
    Life Sci; 1977 Aug; 21(3):301-6. PubMed ID: 19668
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between brain neuroregulators and hypothalamic hormones].
    Zile RK; Klusha VE
    Probl Endokrinol (Mosk); 1979; 25(6):73-9. PubMed ID: 42901
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethanol and cerebral neuroregulators.
    Holman RB
    Biochem Soc Trans; 1983 Jan; 11(1):62-3. PubMed ID: 6130999
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of neurotransmitters in the neocortex.
    Coyle JT
    Neurosci Res Program Bull; 1982 Apr; 20(4):479-91. PubMed ID: 6126844
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metals in the metabolism of cerebral neurotransmitters. Physiological importance and metal-enzyme topographic relationships].
    De Falco FA; Campanella G
    Acta Neurol (Napoli); 1975; 30(2):121-68. PubMed ID: 240251
    [No Abstract]   [Full Text] [Related]  

  • 10. Identifying monoaminergic, GABAergic, and cholinergic characteristics in immortalized neuronal cell lines.
    Gallyas F; Satoh J; Takeuchi AM; Konishi Y; Kunishita T; Tabira T
    Neurochem Res; 1997 May; 22(5):569-75. PubMed ID: 9131635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current hypotheses on the mechanism of action of lithium. I. Lithium and neuromediators].
    Wolf MA
    Encephale; 1987; 13(1):3-11. PubMed ID: 2438125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus encephalitis. Neuroanatomical and neurochemical selectivity.
    Neeley SP; Cross AJ; Crow TJ; Johnson JA; Taylor GR
    J Neurol Sci; 1985 Dec; 71(2-3):325-37. PubMed ID: 3003257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Top 5 Neurotransmitters from a Clinical Neurologist's Perspective.
    Kondziella D
    Neurochem Res; 2017 Jun; 42(6):1767-1771. PubMed ID: 27822666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tranquilizers and neurotransmitters].
    Ueki S; Yamamoto T
    Nihon Rinsho; 1978; 36(1):95-102. PubMed ID: 24769
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphologic and neurochemical studies of embryonic brain development in murine trisomy 16.
    Singer HS; Tiemeyer M; Hedreen JC; Gearhart J; Coyle JT
    Brain Res; 1984 Aug; 317(2):155-66. PubMed ID: 6148129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic mechanisms of target detection - P300 event related potential and striatal dopamine.
    Pogarell O; Padberg F; Karch S; Segmiller F; Juckel G; Mulert C; Hegerl U; Tatsch K; Koch W
    Psychiatry Res; 2011 Dec; 194(3):212-218. PubMed ID: 22104371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter dysfunction in patients with borderline personality disorder.
    Gurvits IG; Koenigsberg HW; Siever LJ
    Psychiatr Clin North Am; 2000 Mar; 23(1):27-40, vi. PubMed ID: 10729929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of strain differences and emotional status of rats on the behavioural and neurochemical effects of chronic treatment with apomorphine.
    Kenny M; Leonard BE
    Prog Neuropsychopharmacol; 1980; 4(2):161-70. PubMed ID: 6105688
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on the neurochemistry of Alzheimer disease.
    Davies P
    Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurohumoral interactions and basal ganglia function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.